KAT2B and posterior cortical atrophy: Collectively these findings reveal conflicting information about GCN5 in prostate cancer, with GCN5 being shown to be a cancer-inhibiting as well as a cancer-promoting factor in the case of PCa and suggests GNN5 might play a context-dependent role in PCa.